Unichem subsidiary should grow by around 22 ... 180-day marketing exclusivity in gPred-forte and the launch of Rivaroxaban tablets. Emerging and RoW markets are expected to grow 11 per cent ...

In a landmark moment for Ghana’s healthcare sector, Unichem Ghana Group was proudly awarded the Excellence in Wholesale & Distribution Award at the maiden edition of the Pharma Excellence Awards ...

Here’s how it works. As of this writing, there is no Pixel Tablet 2. Either way, it seems that Google may abandon its tablet plans with either the Pixel Tablet 2 or Tablet 3 being the last ...

MUMBAI: IPCA Laboratories has signed a definitive agreement to acquire a 33.38 per cent stake in Unichem Laboratories from one of its promoters for Rs 1,034.06 crore. As per a share purchase ...

Ipca, which makes paracetamol tablets under the brand name Pacimol, will also launch an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, according to a ...

Ipca, which makes paracetamol tablets under the brand name Pacimol, is also launching an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, it said in a ...

Unichem Laboratories has received ANDA approval for its Carbamazepine Tablets USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TEGRETOL ...

Unichem Laboratories has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug Administration ...

Unichem Laboratories Limited has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug ...

Unichem Laboratories Limited is pleased to announce that it has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration ...

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension. The ...